-
Daktari Secures $15.5M for Portable Diagnostic
Cambridge-based Daktari Diagnostics is inching towards commercialization of its fast and portable diagnostics platform, securing $15.5 million in equity funding earlier this month with hopes of entering the global market this year.
- Categories
- Health Care
-
The Next Epidemic — Lessons from Ebola
Bill Gates writes: "It's instructive to compare our preparations for epidemics with our preparations for another sort of global threat — war."
- Categories
- Health Care
-
From the Gates Foundation, Direct Investment, Not Just Grants
The Ebola crisis underscored a problem that vexes experts in global health: Vaccines are one of the most cost-effective ways to save lives, especially in developing countries, yet traditional vaccines can take years to develop.
- Categories
- Health Care
-
Gates Foundation makes its biggest-ever equity investment in German biotech
The Bill & Melinda Gates Foundation said it would invest $52 million in CureVac, a German biotechnology company that develops vaccines and immunotherapies, marking the foundation's biggest-ever equity investment.
- Categories
- Health Care
-
Ebola’s low-down on high tech
Advanced equipment has been developed to help protect health-care workers, but the gear may not be helpful in poor countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Triple Jeopardy: Report details the discrimination facing girls and women with leprosy
Report published today warns that the new United Nations Sustainable Development Goals will fail in their aim to “leave no one behind” if discrimination against girls and women affected by leprosy is not tackled.
- Categories
- Education, Health Care
-
PRESS RELEASE: Lighting Science and Global Good to Develop Light-Based Alternatives to Pesticides
Lighting Science Group Corporation and Intellectual Ventures’ Global Good today announced a research agreement to collaborate on the development of next-generation light technologies for pest control.
- Categories
- Health Care
-
Johns Hopkins Researchers Identify Key to Tuberculosis Resistance
The cascade of events leading to bacterial infection and the immune response is mostly understood. However, the molecular mechanisms underlying the immune response to the bacteria that causes tuberculosis have remained a mystery — until now.
- Categories
- Education, Health Care
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.